Tim Anderson
Stock Analyst at B of A Securities
(1.22)
# 1713
Out of 5,234 analysts
19
Total ratings
60.00%
Success rate
13.19%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Pfizer | Reinstates: Neutral | 29 | 26.88 | 7.89% | 1 | Dec 10, 2024 | |
Johnson & Johnson | Reinstates: Neutral | 166 | 143.4 | 15.76% | 1 | Dec 10, 2024 | |
Bristol-Myers Squibb | Reinstates: Neutral | 63 | 56.68 | 11.15% | 1 | Dec 10, 2024 | |
Biogen | Reinstates: Neutral | 178 | 153.15 | 16.23% | 1 | Dec 10, 2024 | |
AbbVie | Reinstates: Neutral | 191 | 179.81 | 6.22% | 4 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Underperform | 565 | n/a | n/a | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Underperform | 41 | 42.54 | -3.62% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Underperform | 256 | 257.65 | -0.64% | 2 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Buy | 121 | 99.73 | 21.33% | 3 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Buy | 109 | 91.03 | 19.74% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Buy | 997 | 764.03 | 30.49% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Peer Perform | n/a | n/a | n/a | 1 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 1 | Sep 22, 2017 |